Page last updated: 2024-08-24

emtricitabine and Dermatoses

emtricitabine has been researched along with Dermatoses in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brieva, J; Kosche, C; Nardone, B; Palella, FJ; Para, A; West, DP	1

Other Studies

1 other study(ies) available for emtricitabine and Dermatoses

Article	Year
Incidence of cutaneous adverse events after exposure to tenofovir-emtricitabine in HIV-uninfected vs HIV-infected patients: pharmacovigilance within a large Midwestern U.S. patient population from the Research on Adverse Drug events And Reports program. Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:12 Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Midwestern United States; Pharmacovigilance; Skin Diseases; Tenofovir; Young Adult	2019

Article

Year

Incidence of cutaneous adverse events after exposure to tenofovir-emtricitabine in HIV-uninfected vs HIV-infected patients: pharmacovigilance within a large Midwestern U.S. patient population from the Research on Adverse Drug events And Reports program.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:12

Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Midwestern United States; Pharmacovigilance; Skin Diseases; Tenofovir; Young Adult

2019